120 Fatal Reactions to the Leptospirosis Vaccine NOBIVAC L4 in its First Three Years…”
Quite the stat from the Daily Telegraph (02/07/16), wasn’t it?! Just another annual booster that we are told is “perfectly safe to be given each year”, which is sadly killing hundreds of dogs in just the UK alone.
This ones for leptospirosis, which is not recommended as a “core” vaccine to be given routinely to your dog unless in a leptospirosis area, though it has, of course, become the norm for all dogs today.
As well as the hundreds dead, owners are reporting swollen glands, epileptic fits and blindness.
….in the last two years, regulators have received 2,000 reports of dogs having suspected adverse or fatal reactions …reports made to the Government’s Veterinary Medicines Directorate (VMD) indicate more than 120 dogs are feared to have died…in the three years the product has been on the market…
The article goes on to tell us:
…the vaccine, which is manufactured by MSD Animal Health, a subsidiary of American conglomerate Merck Sharp & Dohme, is currently being monitored by the VMD…However the regulator has refused to reveal the total number of animals that had been affected since the product came onto the market…
Imagine. The “regulator” not playing ball. Best continue to “monitor” the situation, at least until a few more euro’s are made by the struggling drug company, I guess.
To be fair, the manufacturer states that over a million doses are given per year and that the incidence of side effects in relation to sales, is low. However, while we do not know the actual side-effect figure, reports in the numerous Facebook groups set up to document the harmful effects of this vaccine, such as “Nobivac Lepto 4 – our experiences“, which has 9000 members and growing, including plenty of veterinary testimony, indicate it’s not insignificant. Moreover, I’m not sure a kill rate of 1 in 25,000 doses would be entertained for long in human circles.
Please read on at: https://dogsfirst.ie/leptospirosis-vaccine-nobivak-l4-risks-and-side-effects/
